default_top_notch
default_news_top
default_news_ad1
default_nd_ad1

GC unveils new dysmenorrhea treatment

Lee Han-soo  Published 2018.06.22  14:15  Updated 2018.06.22 19:15

공유
default_news_ad2

GC said Friday it has launched Tak-Sen Eve, a dysmenorrhea treatment.

Tak-Sen Eve, which is a general medicine that combines ibuprofen and pharma bromine, is effective for various pains such as headaches, back pains, toothaches and fevers. The pharma bromine enhances the diuretic effect and calms the swelling of the body, which in turn can help relieve women's symptoms of menstrual pain.

Also, the product uses a Neosol method, which is a patented manufacturing method of soft capsules and has a high absorption rate in the body, thus exhibiting a rapid therapeutic effect. Its liquid form also makes it easy to take, while reducing residual side effects when taking the drug with gastrointestinal diseases such as a sore throat.

“The launch of the product comes from the high demand from our consumers as well as expanding the brand for Tak-Sen,” said Yoon Jin-il, GC’s marketing division team leader. “The company plans to further increase the credibility from our consumers along with our existing Tak-Sen lineup.”

Tak-Sen Eve is packaged in 10 capsules. Depending on the symptoms, users can take the drug one to two times a day.

corea022@docdocdoc.co.kr

<© KBR , All rights reserved.>
default_news_ad5
default_news_bottom
default_nd_ad4
default_bottom
#top
default_bottom_notch